• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

VIDEO: Andrew J. M. Boulton, MD, Discusses Adherence With Non-Invasive Devices

Article

Andrew J. M. Boulton, MD, describes the impact of non-invasive glucose monitoring devices on adherence and hospital admission rates.

Andrew J. M. Boulton, MD, describes the impact of non-invasive glucose monitoring devices on patient monitoring adherence and hospital admission rates and costs. Theoretically, patients using non-invasive glucose monitoring devices will better adhere to regular monitoring than with invasive devices; however, Dr. Boulton says that there is a need for controlled trials to provide evidence-based data to support this conclusion.

This video was taken on June 8, 2012, at the American Diabetes Association's 72nd Scientific Session in Philadelphia, PA.

Related Videos
Diana Isaacs, PharmD
Beau Raymond, MD
Robert Zimmerman, MD
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Leslie Fish, PharmD.
Adam Colborn, JD
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.